These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21606425)

  • 1. Neuroprotection for oxaliplatin-induced neurotoxicity: what happened to objective assessment?
    Park SB; Goldstein D; Lin CS; Krishnan AV; Friedlander ML; Kiernan MC
    J Clin Oncol; 2011 Jun; 29(18):e553-4; author reply e555-6. PubMed ID: 21606425
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimating the value of intravenous calcium and magnesium in ameliorating oxaliplatin-induced neuropathy.
    Atkins CD
    J Clin Oncol; 2014 Oct; 32(29):3341. PubMed ID: 25135996
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of calcium and magnesium salts to reduce oxaliplatin-related neurotoxicity.
    Hochster HS; Grothey A; Childs BH
    J Clin Oncol; 2007 Sep; 25(25):4028-9. PubMed ID: 17664456
    [No Abstract]   [Full Text] [Related]  

  • 4. Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity?
    Cavaletti G
    Oncologist; 2011; 16(12):1667-8. PubMed ID: 22128117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patients.
    Knijn N; Tol J; Koopman M; Werter MJ; Imholz AL; Valster FA; Mol L; Vincent AD; Teerenstra S; Punt CJ
    Eur J Cancer; 2011 Feb; 47(3):369-74. PubMed ID: 21067912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium and magnesium prophylaxis for oxaliplatin-related neurotoxicity: is it a trade-off between drug efficacy and toxicity?
    Khattak MA
    Oncologist; 2011; 16(12):1780-3. PubMed ID: 22128115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of calcium/ magnesium infusion in oxaliplatin-based chemotherapy for colorectal cancer patients.
    Kurniali PC; Luo LG; Weitberg AB
    Oncology (Williston Park); 2010 Mar; 24(3):289-92. PubMed ID: 20394142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxaliplatin-related neurotoxicity: is chelation the solution?
    Hoff PM
    Nat Clin Pract Oncol; 2004 Dec; 1(2):78-9. PubMed ID: 16264824
    [No Abstract]   [Full Text] [Related]  

  • 9. New data question treatment for oxaliplatin neurotoxicity.
    Wolf SL
    Clin J Oncol Nurs; 2008 Feb; 12(1):14; author reply 14. PubMed ID: 18323035
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxaliplatin-related neurotoxicity: interest of calcium-magnesium infusion and no impact on its efficacy.
    Gamelin L; Boisdron-Celle M; Morel A; Poirier AL; Berger V; Gamelin E; Tournigand C; de Gramont A
    J Clin Oncol; 2008 Mar; 26(7):1188-9; author reply 1189-90. PubMed ID: 18309961
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7.
    Grothey A; Nikcevich DA; Sloan JA; Kugler JW; Silberstein PT; Dentchev T; Wender DB; Novotny PJ; Chitaley U; Alberts SR; Loprinzi CL
    J Clin Oncol; 2011 Feb; 29(4):421-7. PubMed ID: 21189381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Reduction of oxaliplatin-related neurotoxicity by calcium and magnesium infusions].
    Muto O; Ando H; Ono T; Itagaki H; Kobayashi Y; Onuki M; Akashi T; Tanaka Y; Hanaoka T
    Gan To Kagaku Ryoho; 2007 Apr; 34(4):579-81. PubMed ID: 17431344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amelioration of oxaliplatin neurotoxicity by drugs in humans and experimental animals: a minireview of recent literature.
    Ali BH
    Basic Clin Pharmacol Toxicol; 2010 Apr; 106(4):272-9. PubMed ID: 20050845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infusion of calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in colorectal cancer: a systematic review and meta-analysis.
    Wu Z; Ouyang J; He Z; Zhang S
    Eur J Cancer; 2012 Aug; 48(12):1791-8. PubMed ID: 22542974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oxaliplatin neurotoxicity].
    Gamelin L; Boisdron-Celle M; Morel A; Gamelin E
    Bull Cancer; 2006 Feb; 93 Suppl 1():S17-22. PubMed ID: 16491518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of the protective effect of calcium-magnesium infusion and glutathione on oxaliplatin-induced neurotoxicity].
    Dong M; Xing PY; Liu P; Feng FY; Shi YK
    Zhonghua Zhong Liu Za Zhi; 2010 Mar; 32(3):208-11. PubMed ID: 20450590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platinum neurotoxicity: clinical profiles, experimental models and neuroprotective approaches.
    Screnci D; McKeage MJ
    J Inorg Biochem; 1999 Oct; 77(1-2):105-10. PubMed ID: 10626361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium and magnesium for oxaliplatin-induced neuropathy.
    Stansfield L
    Am J Health Syst Pharm; 2014 Jun; 71(12):987-8. PubMed ID: 24865753
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute oxaliplatin-induced peripheral-nerve hyperexcitability.
    Schmelz R; Lersch C
    J Clin Oncol; 2002 Aug; 20(16):3561-2; author reply 3562. PubMed ID: 12177120
    [No Abstract]   [Full Text] [Related]  

  • 20. Preventing oxaliplatin-induced sensory neurotoxicity: a methodology perspective.
    Chan A; Chiang J; Lew KY; Chay WY
    J Clin Oncol; 2011 Jun; 29(16):e489; author reply e490-1. PubMed ID: 21482983
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.